Navidea brings Lymphoseek to U.S. market

05/1/2013 | Wall Street Journal, The

Navidea Biopharmaceuticals is launching its lymphatic mapping radiopharmaceutical Lymphoseek in the U.S., the company announced today. Navidea has partnered with Cardinal Health to distribute the product to U.S. health care providers. "Commercialization of Lymphoseek in the U.S. marks a pivotal milestone for Navidea, and we are pleased to deliver this innovative diagnostic imaging agent to patients with breast cancer and melanoma," said Navidea President and CEO Dr. Mark Pykett. Lymphatic mapping helps trace the spread of cancer.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC